Seton Hall University

eRepository @ Seton Hall
Seton Hall University Dissertations and Theses
(ETDs)

Seton Hall University Dissertations and Theses

Fall 12-12-2022

Bis-Indolyl Compounds and the Induction of Apoptosis in T98G
Glioblastoma Multiforme Cells
Margot C. Brown
brownma2@shu.edu

Follow this and additional works at: https://scholarship.shu.edu/dissertations
Part of the Biochemistry Commons, Cancer Biology Commons, and the Cell Biology Commons

Recommended Citation
Brown, Margot C., "Bis-Indolyl Compounds and the Induction of Apoptosis in T98G Glioblastoma
Multiforme Cells" (2022). Seton Hall University Dissertations and Theses (ETDs). 3046.
https://scholarship.shu.edu/dissertations/3046

Bis-Indolyl Methane (BIM) compounds and the Induction of Apoptosis in T98G
Glioblastoma Multiforme Cells
Author: Margot Brown

Submitted in partial fulfillment of the requirements for the
degree of Master of Science in Biology from the
Department of Biological Sciences of Seton Hall University
December 2022

© 2022 Margot Chloe Brown
Seton Hall University
Department of Biological Science

College of Arts and Sciences
Department of Biological Studies
APPROVAL FOR SUCCESSFUL DEFENSE
Margot Chloe Brown has successfully defended and made the required modifications to the text
of the Master’s thesis for the M.S. during this Fall Semester, 2022

DEFENSE COMMITTEE
Dr. Daniel B. Nichols
Mentor
Dr. Suzanne Gantar
Mentor

12/7/22
Date
12/7/22
Date

Dr. Constantine Bitsaktsis.
Committee Member

12/7/22
Date

Dr. Angela Klaus
Committee Member

12/7/22
Date

Dr. Constantine Bitsaktsis
Director of Graduate Studies

12/7/22
Date

Dr. Jessica Cottrell
Chair of the Department

12/7/22
Date

Acknowledgements

First, I would like to thank my loved ones for providing me with unwavering support as I have
moved through my educational career. To my dad, hero, and best friend. The unwavering support
and encouragement you have provided me with throughout this journey is truly something I’ll
never forget. You have always set the example for what it means to be an incredibly strong, yet
kindhearted person. To my mom, thank you for always being my sounding board, and for
teaching me how to navigate through life. And to my sister Cedra, you have always been
somebody that I have greatly admired. You are the embodiment of what it means to work hard to
achieve your dreams. I love you all more than words can describe.
I would also like to thank my mentors Dr. Suzanne Gantar and Dr. Daniel B. Nichols. Thank you
both for your guidance throughout this process. The knowledge that you have passed down to me
is invaluable, and I am incredibly grateful that I was able to work with you.
I would like to thank my committee members Dr. Angela Klaus and Dr. Constantine Bitsaktsis. I
greatly appreciate you taking the time to help me complete my studies here at Seton Hall
University.

Table of Contents:
Abstract………………………………………………………………………...………...Page vii
Introduction……………………………………………………………………………….Page 1
Methods…………………………………………………………………………………...Page 3
Results…………………………………………………………………………………….Page 6
Conclusion and Discussion……………………………………………………………...Page 16
References……………………………………………………………………………….Page 19

v

List of Figures:
Figure 1 Molecular structure of 1,1-bis(3’idolyl)-1(aryl)methane compound……...….Page 8
Figure 2 SRB Data………………………………………………………..…………..……Page 9
Figure 3 SRB Log Concentration vs Absorption for BIM Compounds……………….Page 10
Table 1 EC50 Values for BIM Compounds.……………………………………………..Page 11
Figure 4 PPARγ Expression in T98G cells……………………………………………....Page 12
Figure 5 BAX Expression in T98G cells…………………………………...…………….Page 14
Figure 6 Cleaved Caspase 3 Expression in T98G Cells.…………..……………………Page 15

vi

Abstract:
1,1-bis(3’idolyl)-1(aryl)methane compounds (BIM compounds) have been shown to have
anti-cancer properties in colon cancer, bladder cancer, and leukemia cells. The purpose of this
work was to determine if BIM compounds could be an effective treatment of glioblastoma
multiforme. Sulforhodamine B (SRB) assays showed that 20µM of the BIM compounds could
inhibit cellular proliferation of the T98G glioblastoma multiforme cell line over 72 hours. Then
immunoblotting was used to analyze the molecular pathway induced by BIM compounds. An
increase in the expression of both BAX and cleaved caspase 3 suggest BIM compounds activate
programmed cell death, or apoptosis in glioblastoma cells. In conducting this work, I am hoping
to contribute to the creation of a new treatment for glioblastoma multiforme that will minimize
the negative side effects of traditional cancer treatments.
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Introduction:
Glioblastoma multiforme is a brain tumor categorized as a stage IV astrocytoma.
Glioblastoma multiforme differs from astrocytoma in that it is made up of more than one type of
glial cell, primarily astrocytes and oligodendrocytes, whereas astrocytoma solely consists of
cancerous astrocytes (National Cancer Institute). With a recurrence rate of 90% in those who
seek treatment, as well as a five-year survival rate of 6.8% (National Brain Tumor Society),
glioblastoma multiforme, is the deadliest cancer that can develop in adults in the United States.
Additionally, individuals over the age of 65 who are diagnosed with glioblastoma multiforme
have a survival rate of only 2% (Wirsching et. al 2016), indicating that age is a predominant risk
factor in the poor prognosis of glioblastoma multiforme (Wirsching et. al 2016).
Glioblastoma multiforme not only have a poor prognosis but are also associated with a
plethora of symptoms including edema, epilepsy, memory loss, loss of motor function, and
generalized destruction of brain tissue (Wirsching et. al 2016). Methods of obtaining a sample of
the tumor for extensive analysis such as performing stereotactic biopsy or microsurgical
resection of the tumor is needed to diagnose glioblastoma (Wirsching et. al 2016).
Glioblastoma multiforme can be divided into two subtypes consisting of primary or
secondary glioblastoma multiforme tumors. Primary, or de novo glioblastoma tumors are
growths which originate in the brain. Secondary glioblastoma multiforme tumors are typically
deposited in the brain when malignant and metastatic cells from a tumor originating somewhere
else in the body breaks off and enter the individual’s nervous system. Additionally, secondary
glioblastoma multiforme is a more common diagnosis among adolescence as it is developed
from a cancer independent of the nervous system, known as astrocytoma. Isocitrate
dehydrogenase 1 (IDH1) genetic mutations are commonly associated with a secondary
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glioblastoma multiforme diagnosis (Ohgaki 2013). IDH1 is typically found in the cytoplasm of
somatic cells and is primarily responsible for fat metabolism and the breakdown of molecules
which could be harmful to the cell (National Cancer Institute). Loss of function mutations in the
IDH1 gene may lead to abnormal cell development which may cause some cells to become
cancerous (National Cancer Institute).
Current treatment of glioblastoma multiforme consists of radiotherapy as well as surgical
resection. Both radiotherapy and surgical resection present a variety of negative side effects
which can be detrimental towards the physical wellbeing of the individual seeking treatment.
Regardless of treatment, glioblastoma multiforme has an extremely poor prognosis (Taylor et. al
2019).
1,1-bis(3’idolyl)-1(aryl)methane compounds, or “BIM” compounds have anti-cancerous
properties (Shorey et. al, 2012) in a variety of cell lines such as colon cancer, bladder cancer, and
acute myelogenous leukemia (Contractor, 2005; Kassouf, 2006: Chintharlapalli, 2005). BIM
compounds are also used for their anti-fungal and anti-inflammatory properties, as well as their
ability to contribute to cardiovascular health by way of inhibiting the enzyme cyclooxygenase
which causes edema (Kaishap, 2013).
The peroxisome proliferator-activated receptor γ (PPARγ) is a nuclear hormone receptor
which may play a role in cancer suppression (Vandoros et. al 2005). Activation of PPARγ have
been proven to moderate lipid and glucose metabolism, cell growth, immune function, cell
differentiation, and adipogenesis (Vandoros et. Al, 2005). PPARγ activation has also been shown
to induce intrinsic apoptotic pathways by facilitating the synthesis of pro-apoptotic proteins such
as cleaved caspase 3 (Garcia-Bates et. al 2008). PPARγ is targeted in this research due to its high
level of expression in various cancer types including multiple myeloma as well as primary

2

metastatic breast cancer (Wang, 2013; Garcia-Bates, 2008). BIM compounds and their
derivatives have been proven to be PPARγ receptor agonists (Chintharlapalli, 2005; Kassouf,
2006: Contractor, 2005).
Side effects of existing cancer treatments are detrimental to the health of the individual.
The purpose of the present study is to investigate the BIM compounds as a potential new
treatment for glioblastoma multiforme. New treatments are needed to improve patient survival
rates and reduce the negative side effects of current cancer treatments.

Methods:
Cell Culture
T98G glioblastoma multiforme cell line (ATCC, Manassas, VA) was maintained using
Dulbecco’s Modified Eagle Medium (DMEM; Sigma-Aldrich,St. Louis, MO). The final DMEM
product used by researchers contained 10% Fetal Bovine Serum, 1% non-essential amino acids,
1% Penicillin Streptomycin, and 1% L-glutamine (Gibco, Gaithersburg, MD). Incubation of
T98G cells took place at 37oC and 5% CO2.
BIM Compounds
BIM compounds were produced by the Badillo lab at Seton Hall University using a minor
photoacid catalysis reaction (Salem, et. al). BIM compounds were received from the Badillo lab
in a solid form and were consequently dissolved in DMSO to 20mM concentration before being
used in this research.
Sulforhodamine (SRB) Assay
Cell proliferation was measured using a procedure previously established by Esteban A
Orellana and Andrea L Kasinkski (Orellana and Kasinski, 2016). Cells were plated in 96-well
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plates in quintuplicates with a density of 3,500 cell per well. Following a 3-hour incubation
period, the media was aspirated out of each of the wells and 100 µL of the desired BIM
compound was placed in each well at various concentrations, ranging from 5 µM to 50 µM. BIM
compounds were dissolved in DMSO and stored at 4 oC. Plates were left to incubate at 37oC for
72 hours. Following the 72-hour incubation period, the BIM solution was aspirated from each of
the wells, and cells were washed with 1X Phosphate Buffer Saline (PBS). 20% trichloroacetic
acid (TCA) was used to then fix the cells to the plate (Sigma-Aldrich). Following cell fixation,
plates were rinsed with tap water and cells were stained using a 1% acetic acid and
Sulforhodamine B v/w solution (Sigma-Aldrich). Plates were dried and cells were resuspended
in 1mM Tris. Imaging the absorbance of the plates was conducted at a 505nm wavelength using
a Varioskan™ LUX multimode microplate reader which was obtained from Sigma-Aldrich.
Treating Cells for Immunoblotting
Cells were plated in T75 flasks or 6 well plates and allowed to reach 40% confluency.
Treatments were diluted in DMEM. Control groups consisted of DMSO (0.025%), rosiglitazone
(20µM), and cycloheximide/TNF-alpha (10ng/mL: 1µL/mL) (Sigma-Aldrich,St. Louis, MO).
Treatments were allowed to run for 6.5 hours. Media was then aspirated, and cells were washed
with PBS. The washing solution was aspirated from the cells, at which point cells were
trypsinized and their pellets were collected.
Immunoblotting
A RIPA buffer solution containing a protease inhibitor (Pierce, Rockford, IL) was used to
lyse cells. Concentration of protein in the lysate was established by BCA assay (Pierce,
Rockford, IL). 30 µg of protein was separated using 10% SDS page running buffer, then
transferred to a nitrocellulose membrane. Transfer was facilitated using Trans-Blot Turbo
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Transfer System™ (Philadelphia, PA). 5% milk in TBS-T was used to block the membrane at
room temperature for 1 hour on a rotator.
For a manual transfer, the gel membrane was removed from plastic encasement and
submerged in a transfer buffer for ten minutes. Transfer buffer was made using tris base (SigmaAldrich,St. Louis, MO), glycine (Sigma-Aldrich,St. Louis, MO) and methanol. Two pieces of
filter paper and two square sponges were also submerged in the same transfer buffer for ten
minutes. PVDF transfer membrane was allowed to sit in 100% methanol for approximately two
minutes. The materials were removed from the transfer buffer. A gel holder cassette was used to
hold the materials together during transfer. First, a square sponge was placed on the gel holder
cassette, followed by a piece of filter paper, then the gel membrane. The PVDF membrane was
then placed on top of the gel membrane, followed by a second piece of filter paper and a second
square sponge. The gel cassette was then placed in an electrode assembly in a buffer tank with
one ice pack. The tank was filled to the top with transfer buffer, and transfer was allowed to take
place for 1hour at 90mV.
Following transfer, a 5% milk in TBS-T was used to block the membrane at room
temperature for 1 hour on a rotator. The block was aspirated from the membrane and the
membrane was then incubated overnight with a primary antibody at 4oC on a rotator. BAX (Cell
Signaling Technology, Danver, MA), cleaved caspase 3 (Cell Signaling Technology, Danver,
MA), and β-actin antibodies (Cell Signaling and Santa Cruz Biotechnology, Dallas, TX) were
used at a 1:1000 dilution. Both anti-mouse and anti-rabbit horseradish peroxidase-linked
antibodies were used as secondary antibodies at a 1:1000 dilution (Cell Signaling Technology)
when probing for BAX, while the anti-rabbit horseradish peroxidase-linked secondary antibody
was used at a 1:10,000 dilution when probing for cleaved caspase 3. The appropriate secondary
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antibody was placed on the membrane, and the membrane was incubated overnight at 4 oC on a
rotator. SuperSignal West Femto substrate was used in detection. Images of the western blots
were taken on a FluorChem™ E system (ProteinSimple, Santa Clara, CA).
Quantification of Western Blot
The NCBI ImageJ software was used in quantification of the western blot. The lanes in
which BAX and cleaved caspase 3 bands appeared in western blot imaging were selected and
consequently differentiated. Using the ImageJ software, the lanes with the corresponding graphs
were plotted, producing graphs. The graph appeared as a curve and the surface area of the curve
corresponded to the amount of protein in the band, which was then given a percentage value
depending on the total BAX or cleaved caspase 3 expression appeared in the given lane. Band
quantification was then repeated for β-actin expression in each lane. The data was then
normalized, and the ratio of BAX or cleaved caspase 3 to β-actin for each band was established.
Statistical Analysis
GraphPad Prism software (La Jolla, CA) was also used to calculate EC50 values from the
SRB absorbance data that was previously collected. Microsoft excel (Redmond, WA) was used
to conduct one-way anova testing following western blot quantification. P-values less than 0.05
were considered statistically significant.

Results:
BIM compounds inhibit T98G cell proliferation
Previous research has shown that BIM compounds inhibit cellular proliferation in cancers
such as bladder cancer (ZMS1-109 and ZMS1-120) and leukemia (ZMS1-146) (Kassouf et. al;
Contractor et. al) (Figure 1). The effect of BIM compounds on the cellular proliferation of
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glioblastoma multiforme cells has not previously been measured. The adherent cell line T98G
derived from a 61-year-old white male was obtained from the ATCC. Cell density of T98G cells
was measured 72 hours after BIM treatment using a Sulforhodamine B (SRB) assay. As seen in
Figure 2, cell proliferation was significantly inhibited by all three BIM compounds at 20µM
concentration compared to DMSO control.
Absorbance was compared to the log concentration of BIM compounds to calculate EC 50
values. EC50 values correspond to the concentration of the given BIM compound in which halfmaximal effect was measured. Compounds ZM-109, ZM-120 and ZM-146 had EC50 values of
16.72 µM, 13.34 µM, and 11.07 µM respectively (Figure 3, Table 1).
BIM compound 146 inhibits T98G proliferation through activation of apoptosis
BIM compounds induce apoptosis the bladder cancer cell lines KU7 and 253J-BV
through activation of PPARγ (Kassouf et. al). T98G cells have been shown to express PPARγ
(LIU, et. al), which was confirmed here (Figure 4).
Next, expression of BAX was measured in the T98G cell line. Cells were treated cells
with 5uM of ZMS1-146 for 6.5 hours. To ensure that DMSO did not have a cytotoxic effect on
cells, T98G cells were treated with DMSO alone. Rosiglitazone was used as a PPARγ agonist in
this research.
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*All molecular structures in this paper were generated by the author of this
paper and all subsequent images were generated by the author of this paper.

Figure 1. Molecular structure of 1,1-bis(3’idolyl)-1(aryl)methane
compound ZMS1-146 (A), ZMS1-120 (B), AND ZMS1-109 (C)
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Figure 2. The concentration of BIM compound used to treat T98G cells
compared to its absorbance under 520nm after 72 hours of treatment.
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Figure 3. SRB Log Concentration vs absorption for BIM compounds A) ZMS1-109
B) ZMS1-120 C) ZMS1-146
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BIM Compound

EC50 Value

ZMS1-109

16.72µM

ZMS1-120

13.34µM

ZMS1-146

11.07µM

Table 1. EC50 values for the BIM compounds.

11

Figure 4. Western blot analysis of PPARγ in T98G cells. This figure was
generated by Gantar Lab undergraduate researcher Matthew Sunda.
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As seen in Figure 5, BAX was more highly expressed in cells treated with the BIM treatment
compared to the control groups. A one-way ANOVA test was used to calculate a p-value for this
experiment. The p-value was determined to be 0.0012.
Expression of cleaved caspase 3 was measured in the T98G cell line. Cells were treated
cells with 5µM of ZMS1-146 for 6.5 hours. As seen in Figure 6, cleaved caspase 3 was more
highly expressed in our BIM treatment group than it was in the groups treated with
cycloheximide/TNF-alpha and 0.025% DMSO. A one-way ANOVA test was used to calculate a
p-value for this experiment. The p-value was determined to be 0.0359.
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Figure 5. Western blot analysis of BAX in T98G cells A) BAX was more highly
expressed in T98G cells that were treated with 5 µM ZMS1-146 compared to DMSO
and Rosiglitazone. B) Quantification and consequent statistical analysis of the bands
produced by western blot proved that the expression of BAX in the experimental
group is higher than that of the control groups to an extent of being statistically
significant. A one-way ANOVA test produced a p-value of 0.0012.

14

Figure 6. Western blot analysis of cleaved caspase 3 expression in T98G cells A)
Cycloheximide/TNF-alpha treated cells acted as the positive control. Cleaved caspase 3
was more highly expressed in T98G cells that were treated with ZMS1-146. B)
Quantification and consequent statistical analysis of the bands produced by western blot
proved that the expression of cleaved caspase 3 in the experimental group is higher than
that of the control groups to an extent of being statistically significant. A one-way
ANOVA test produced a p-value of 0.0359.
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Discussion and Conclusions:
This research sought to determine if BIM compounds could be used as a therapeutic
against glioblastoma multiforme. All three BIM compounds tested inhibited proliferation of
T98G glioblastoma multiforme cells. Compound 146 was then further examined to determine
how BIMs inhibit proliferation. BAX and cleaved caspase 3 protein levels increase after 6.5
hours of treatment with 5µM BIM suggesting activation of apoptosis. The BIM compound may
be signaling through the PPARγ which is present in the cells.
The EC50 values calculated for the three compounds that were focused on in this
experiment ranged from 11.07µM to 16.72µM. A low EC50 value indicates that a smaller amount
of drug is needed to inhibit cellular proliferation, while a high EC50 value indicates that the drug
is less potent. In a study conducted by A. Saveanu et. al, researchers determined the effects of
BIM compounds binding to different receptors in human pituitary somatotroph adenoma cells.
The purpose of their research was to determine if BIM-23A387 was capable of suppressing
growth hormone production in human pituitary somatotroph adenoma cells. Researchers tested
the effects of the BIM compound of interest on receptors sst1-sst5. EC50 values were produced
ranging from 0.1M (sst1), to 1000M (Saveanu et. al). Generally, the concentration of the BIM
compound used in this research to produce a half maximal response in the cancer of interest far
exceeded that which was observed in the present study. The larger EC50 values obtained by
Saveanu et. al may be a result of their research utilizing in vivo studies. Should the present study
be continued in the future and moved from in vitro to in vivo testing, the EC50 values may be
larger.
In research conducted by Lyndsey E. Shorey et. al, scientists investigated the effects of
3,3-diindolylmethane (DIM) compounds on acute lymphoblastic leukemia (Shorey et. al).
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Researchers conducted an in vitro study using cell lines CEM and SUP-TI (Shorey et. al). In
conducting this study, researchers hypothesized that a decrease in cellular proliferation would be
observed upon exposing acute lymphoblastic leukemia cells to the DIM compounds of interest.
Moreover, researchers observed that the expression of cell division protein kinases such as
CDK4 and CDK6 significantly decreased following exposure to DIM compounds (Shorey et. al).
CDK4 and CDK6 expression was observed via western blotting. In addition to measuring the
expression of cyclin dependent protein kinases, Shorey et. al established that the cells were
undergoing apoptosis following DIM exposure using ViaCount Assay + (Shorey et. al). The
ViaCount Assay + was also used by researchers to examine cellular proliferation following
exposure to the DIM compounds of interest. EC50 values were then calculated for the experiment.
The EC50 for cell line CEM was determined to be 15µM, while the EC50 value for cell line SUPTI was 13µM (Shorey et. al). The data pertaining to cellular proliferation and EC50 values
collected in this research is similar to that which was obtained in the present study.
Expression of BAX and cleaved caspase 3 in T98G cells treated with the BIM compound
of interest suggest that an intrinsic apoptotic pathway was activated in the cancer cells. Intrinsic
apoptotic pathways refer to a stress response within the cell that causes apoptosis, while an
extrinsic apoptotic pathway refers to the extracellular environment dictating that the cell is no
longer able to live (Thermo-Fischer Scientific). Expression of BAX in T98G cells treated with
ZMS1-146 was significantly greater than the expression of BAX in the control groups.
Expression of BAX in cells treated with rosiglitazone was lower than expected. Rosiglitazone is
known to be a PPARγ agonist (Cuzzocrea et. al), however in this experiment rosiglitazone
treatment produced less BAX expression compared to the negative control DMSO. Similar
results were obtained when observing cleaved caspase 3 expression in T98G cells. Again,
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DMSO was tested on the T98G cells to ensure that it did not have a cytotoxic effect on the
cancer cell line. Cycloheximide/TNF-alpha was used as the positive control group because these
compounds are known to induce apoptosis (Rath and Aggarwal; Dai et. al). Expression of
cleaved caspase 3 in BIM treated T98G cells was significantly greater than that of either one of
the control groups, suggesting that an intrinsic apoptotic pathway was activated in the T98G cells
upon exposure to ZMS1-146.
Previous research, as well as preliminary docking studies have suggested that BIM
compounds bind to the PPARγ receptor, consequently inducing apoptosis in the cell. Future
studies could be done to determine if BIM compounds are binding to the PPARγ receptor to
induce apoptosis. T98G cells could be manipulated to over-express the PPARγ receptor.
Researchers could then observe whether the BIM compounds are more effective in inducing
apoptosis in cells with the over-expression. Moreover, the PPARγ could be entirely deleted from
the T98G cell line, and researchers could test whether BIM compounds are still capable of
inducing apoptosis in the cell line.
Throughout this research, BIM compounds have been shown to increase BAX and
cleaved caspase 3 expression in T98G glioblastoma multiforme cells. The increased expression
of these pro-apoptotic proteins was observed via western blotting. Moreover, BIM compounds
decrease cellular proliferation of T98G glioblastoma multiforme cells, which was measured
using SRB assay.
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